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Abstract
Background: A rare or orphan disease (OD) is any disease that affects a small percentage of the population. While
opportunities now exist to accelerate progress toward understanding the basis for many more ODs, the
prioritization of candidate genes is still a critical step for disease-gene identification. Several network-based
frameworks have been developed to address this problem with varied results.
Result: We have developed a novel vertex similarity (VS) based parameter-free prioritizing framework to identify
and rank orphan disease candidate genes. We validate our approach by using 1598 known orphan disease-causing
genes (ODGs) representing 172 orphan diseases (ODs). We compare our approach with a state-of-art parameter-
based approach (PageRank with Priors or PRP) and with another parameter-free method (Interconnectedness or
ICN). Our results show that VS-based approach outperforms ICN and is comparable to PRP. We further apply VS-
based ranking to identify and rank potential novel candidate genes for several ODs.
Conclusion: We demonstrate that VS-based parameter-free ranking approach can be successfully used for disease
candidate gene prioritization and can complement other network-based methods for candidate disease gene
ranking. Importantly, our VS-ranked top candidate genes for the ODs match the known literature, suggesting
several novel causal relationships for further investigation.
Background
In the USA, a rare or orphan disease (OD) is defined as a
disease that affects fewer than 200,000 inhabitants [1].
According to an estimate, there are as many as 8000 ODs,
many of which are known to be of genetic origin, affect
children at a very early age and are life-threatening and/or
chronically debilitating [2,3]. Although, the advent of next-
generation sequencing technologies accelerates the disease
gene discovery pipeline, the prioritization of candidate
genes is still a critical step for disease-gene identification
[4]. We [5], and several other earlier studies [6-9], have
shown that genes associated with phenotypically close dis-
orders tend to share molecular signatures which include
similar expression profiles, participation in the same biolo-
gical processes or pathways, protein interactions or
complexes, literature co-citation. We have recently com-
pleted a global analysis of all ODs that have at least one
known mutant gene associated (data from Orphanet [10]
and the OMIM databases [11]) and show that the relation-
ship between ODs cannot be fully captured by the gene-
based network alone. Integrating diverse biomedical and
genomic data types can facilitate hypotheses synthesis
about disease causing mutant genes. Additionally, it can
help in addressing an important question, namely, are
there any candidate genes related to known causal genes for
a disease? A useful way to approach this question is to
rank the genes in a test set based on their similarity to a
reference or ‘seed’ set. Such a “guilt by association” ranking
approach has become an important way to prioritize candi-
date disease genes, such as the candidates found in gen-
ome-wide association or linkage studies [12]. The genes
within a locus shown to be linked to a particular disease,
for example, can be prioritized based on their similarities
to a reference set of known genes for that disease. We and
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others have developed several computational approaches
which perform this task automatically [4,13-23].
Network-based analyses have been equally successful in
the identification and prioritization of disease candidate
genes [6,7,24-31] especially where the genes are relatively
less annotated. Network-based candidate gene ranking
approaches can be broadly grouped into two categories:
parameter-based and parameter-free methods. The para-
meter-based methods, such as PageRank with Priors (PRP
[28]), Random Walk (RW [27]) and PRIoritizatioN and
Complex Elucidation (PRINCE [7]), usually require addi-
tional auxiliary parameters that need to be trained by
using available data sets. The PRP for instance needs a
parameter b to control the probability of jumping back to
the initial node [28], and the PRINCE algorithm uses a
parameter to describe the relative importance of prior
information [7]. Since selecting optimal parameters could
be a challenge, parameter-free approaches are preferred
and considered as more user-friendly [29]. Additionally,
most parameter-based approaches take into account the
global information in the entire network which often
requires extensive computation. For example, in PRP,
scores of all the nodes need to be updated iteratively until
they converge. This process typically becomes extremely
slow and inefficient especially when the network size is
large. The parameter-free methods (e.g. Interconnected-
ness or ICN [29]), on the other hand, measure closeness
of each candidate gene to known disease genes by taking
into account direct link and the shared neighbors between
two genes and tend to be less intensive computationally.
The performance of parameter-free methods however is
usually not comparable to parameter-based ranking
approaches. Here, we report a novel network-based para-
meter-free framework for discovering and prioritizing can-
didate orphan disease genes. We specifically focus on two
aspects: a) enhance prioritizing performance compared to
current parameter-free methods and b) achieve a compar-
able performance to the parameter-based ones. We test, in
a leave-one-out cross-validation setting, the utility of our
approach in prioritizing genes for 172 ODs with at least
five known causal genes (from Orphanet database [10]).
We compare the performance of our method to two
approaches, one each from parameter-based and para-
meter-free methods. To demonstrate the utility of our
approach, we rank the immediate neighbors of known OD
genes as potential novel candidate genes. The immediate
neighboring gene sets were compiled using (a) protein
interactions; (b) functional linkage network [32,33]; and
(c) literature co-citations.
Results and discussion
Vertex similarity (VS) based candidate gene ranking
Hypothesizing that genes that are connected to one or
more known disease genes (“seed genes”) are also
probably implicated in the same disease, our goal is to
find such novel candidate genes with “strong” associa-
tions to the seed genes. Our proposed VS-based candi-
date gene ranking approach is based on guilt-by-
association principle. Two nodes or vertices are consid-
ered similar if their immediate neighbors in the network
are themselves similar (common biological process,
pathway, etc.). This principle is used to build a self-con-
sistent matrix formulation of functional similarity that
can be evaluated iteratively using only knowledge of the
adjacency matrix of the network (based on functional
annotations of genes). To this effect, we consider simi-
larity between two vertices (genes) as a measure of their
association strength in a network. Thus, two vertices
with a high similarity are likely to be strongly related. In
order to find the similarities between the seed and the
candidate or test set genes, we introduce a vertex simi-
larity measurement in our algorithm. Vertex similarity
which defines the similarity of two vertices based on the
structure of network has been used for information
retrieval in World Wide Web [34] and in social network
analysis [35]. Similarity measurements, such as cosine
similarity, have been successfully applied for computing
similarity between documents which are described as
vectors of keywords [36]. However, to the best of our
knowledge, there have been no reports of using it as a
measure to compute similarity between two genes in a
functional network and use it for ranking candidate dis-
ease genes.
In our approach, when two genes are connected, the
gene vectors are constructed based on protein interac-
tions with the other neighboring genes. The shortest
path is considered in cases where two genes are not
directly connected. As illustrated in Figure 1, the simi-
















where ωA, i represents the edge weight of node A to
node i, and we define ωA, A = ωB, B = 1 (protein interac-
tions); n is the number of the nodes which includes A,
B and all the nodes that are directly associated with A
and B. Equation 1 applies only when nodes A and B are
connected and hence the value of n can be derived by
n = A + B − σshared (2)
where ΓA and ΓB represent the degree (number of
connections or edges the node has to other nodes) of
nodes A and B respectively, and sshared = | ΓA ∩ ΓB |
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and represents the number of shared neighbor nodes by
both A and B.
When there is no direct connection between node A
and node B, we try to find the shortest path between








if K ≤ r
otherwise
(3)
where Ck is the node on the shortest path of A and B,
and r is the discovery range that controls the maximum
degree of separation (maximum r hops). In other words
if the shortest path length between nodes A and B is
more than r hops or if there is no shortest path between
them, Sim(A, B) equals to 0.
The candidate genes in the test set are prioritized based
on the similarity scores calculated from equation 1 and
equation 3. For example, for a given disease d, each can-
didate gene is scored by summing up the similarity scores
between the candidate gene and each of the seed genes
from the training or seed set Sd. The score of a candidate





where Sim(i, j) is the connection score between gene i
and j. All candidate genes are then ranked based on
these scores.
Comparison with other network-based prioritization
algorithms
To compare the performance of our VS-based approach
in candidate disease gene ranking, we select two meth-
ods, one each from parameter-based and parameter-free
methods: PageRank with priors (PRP) [28] and Intercon-
nectedness (ICN) [29]. Parts of implementation of PRP
are done using JUNG (Java Universal Network/Graph;
jung.sourceforge.net) framework [37] as described earlier
[28]. To evaluate the performance of VS-based approach
and compare it with two other methods, we used a
leave-one-out cross-validation procedure. In each cross-
validation trial, we removed a single OD causal gene
("target gene”) from the data, and each of the 3 algo-
rithms was evaluated by its success in assigning the rank
to the “target gene” (see Methods for additional details).
We selected 172 ODs (ODs with 5 or more known
causal genes) and 1598 OD causal genes for the cross-
validation runs. Of the 1598 genes, we used 1312 which
were in the protein interactome. The results from the
leave-one-out cross-validation using the three
approaches are presented in Figure 2. As can be seen
Figure 1 Illustration of the connections between hypothetical genes A and B. Each node represents a gene and each edge represents
either a physical interaction or functional association. ω is the weight of each connection which in case of protein interactions is 1.
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from the Figure 2, when k (rank cut-off) = 1, both VS-
based (parameter-free) and PRP (with back probability
set to 0.3; parameter-based) methods, achieved the best
performance with a success rate of ~43%. In other
words, the target gene was top ranked in 568 out of
1312 cases (43.3%) using VS-based method. On the
other hand with PRP (0.3 back probability), the target
gene was top ranked 559 times out of a total 1312 cases
(42.6%). ICN, another parameter-free method showed a
lower success rate at 35.3% with the target gene ranked
at top 463/1312 times. Expectedly, PRP (with back prob-
ability set to 0.05) showed a lower success rate than VS
at 37.2% (488/1312) but was better than ICN.
When we increased the rank cut-off (k), VS-based
approach performed equally well as PRP0.3. Additionally,
compared to ICN, another parameter-free method, our
VS-based approach performed better. We also note that
VS outperformed PRP too when the back probability was
set to 0.05.
The improved performance of VS over ICN we believe
is because of the “extended guilt by association” [38]
principle on which VS is based on. For example, if we
consider a simple unweighted network (Figure 3; all
edges equal to 1) where nodes A and B do not have a
common neighbor and the shortest path connecting
them is A-C-D-B. In this case, the ICN [29] score would
be 0 because there is not even a single shared node
between A and B. However, using VS, we can calculate
the similarity between A and B (Sim(A, B) = Sim(A, C)
*Sim(C, D)*Sim(D, B) = 0.276). Although, we have not
performed an extensive analysis on disease gene connec-
tivity, for the examples we have analyzed, we have found
that several causal genes of a specific disease are con-
nected indirectly (e.g., 3-step away).
However, since biological networks tend to have low
diameters [39], we believe that low values of the steps/
hops are preferable. Interestingly, a previous study pro-
vided examples of two real data applications where the
number of hops or steps between disease causal genes
(m) were set to two and reported that m = 2 was prefer-
able over m = 1 [40]. Since the edge information
between two genes may be noisy or incomplete, we
believe that our VS-based approach for novel candidate
disease gene ranking is desirable as it takes into account
alternative measures of pairwise interconnectedness and
is not just limited to direct interactions or having a
shared neighbor node.
Identifying and ranking novel OD candidate genes with
VS-based approach
Having validated our method, we proceeded to execute
our algorithm on several ODs with the goal of identifying
and ranking potential novel candidate genes for ODs. We
ranked candidate genes over the entire protein-protein
interaction (PPI) network, and analyzed our top-five pre-
dictions for ten select ODs which have known protein
interactions for all of their causal genes. The test set genes
were compiled using several different sources comprising
Figure 2 Comparison of performance of parameter-based (PRP) and parameter-free (VS and ICN) methods in candidate gene ranking.
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protein interactions, functional relatedness and literature
co-citations. Briefly, for each causal gene of an OD, we
extracted the immediate neighboring genes from the
above mentioned resources (see Figure 4 and Methods for
additional details). Table 1 shows the top-five predictions
for ten ODs. We checked whether our VS top-ranked
genes were already found to be associated with their query
OD by searching online databases and scientific publica-
tions and found that most of the top candidate genes were
already related to the respective OD. For example, the top
five predictions for cone rod dystrophy are CRB1, RDH5,
USH1C, EFEMP1, CABP4, which are genes associated
with visual perception (Gene Ontology) and two of them
(CRB1 and CABP4) are known to be involved in eye
photoreceptor cell development and differentiation
[41-43]. For this particular example, we also performed
candidate gene ranking using PRP (with back probability
set to 0.3) and ICN. We also used a functional annotation
based candidate gene ranking method (ToppGene [16])
for ranking. When we compared the twenty top ranked
genes from each of these three methods with VS-based
ranking, there were five genes (CRB1, EFEMP1, NPHP4,
CNGB1 and GUCA1B) common to all (Figure 5).
Among other examples, HES1, the top ranked gene for
Fanconi anemia is a novel interacting protein of the Fan-
coni anemia core complex and cells depleted of HES1
exhibit a Fanconi anemia-like phenotype [44]. The two
top-ranked genes for gonadal dysgenesis, ZFX and ZFY,
are known to function in sex differentiation and Zfx
mutant mice are reported to have fewer germ cells than
wild-type mice [45]. Likewise, maturity-onset diabetes of
the young type (MODY syndrome) is linked to kinetic
alterations and regulation of glucokinase activity [46,47]
and in our ranking glucokinase receptor is the top ranked
gene for MODY syndrome. Interestingly, a recent study
in the Japanese families proposes GCKR as a susceptibil-
ity gene for familial diabetes [48]. While our ranking pro-
vides further support for the involvement of the top-
ranked ranked genes in the investigated ODs, it also sug-
gests that the top scoring candidates that are not pre-
viously associated with these ODs could be potential
candidates for further research.
Conclusion
The vertex similarity method (VS) is parameter-free
approach for prioritizing candidate disease genes, where
it calculates the similarity between nodes other than
updating and training the parameters and data sets in
every step. Through cross-validation experiments we
show that VS outperforms ICN, another parameter-free
method and that it is comparable to parameter-based
methods such as PRP. We demonstrate the utility of VS-
based parameter-free ranking approach in ranking OD
candidate genes and importantly, these top ranked candi-
date genes for the ODs match the known literature, sug-
gesting several novel causal relationships for further
investigation.
Our approach however has some limitations. First, as
with any training set dependent candidate gene ranking
approaches, we assume that the OD causal genes we have
yet to discover will be consistent with what is already
known about an OD and/or its genetic basis which may
Figure 3 An example network with indirect connections between hypothetical genes A and B. Nodes A and B do not have a common
neighbor and the shortest path connecting them is A-C-D-B.
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Figure 4 Workflow for identifying and ranking novel OD candidate genes using VS.
Table 1 Examples of orphan diseases and VS-ranked top 5 candidate genes
Orphan disease No. of known causal genes VS ranked top 5 candidate genes
Cone rod dystrophy 20 CRB1, RDH5, USH1C, EFEMP1, CABP4
Severe combined immunodeficiency 17 CD3G, JAK1, ZAP70, IL2RB, IL4
Fanconi anemia 15 HES1, SAMD3, CYP19A1, XRCC3, USP1
Zellweger syndrome 14 PEX7, PHEX, ABCD2, ABCD1, ABCD3
Autosomal dominant Charcot-Marie-Tooth disease, type 2 12 STAT4, FAIM, MARCH5, STAT6, CRYGC
Gonadal dysgenesis 12 ZFY, ZFX, PTCH2, SOX9, AMH
Hereditary nonpolyposis colon cancer 11 MRC1, MSH3, CARKD, TRIT1, EXO1
Papillary or follicular thyroid carcinoma 11 CORO2A, ZBTB33, KIF11, AAAS, SEH1L
Romano-Ward syndrome 11 KCNE3, MINK1, KCNJ3, ALG10B, KCNJ9
MODY syndrome 10 GCKR, IDDM7, MAFA, ST6GAL1, INSRL
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not always be the case. Additionally, this also means that
our approach currently cannot be used to rank novel
candidate OD genes if an OD lacks known causal genes.
Similarly, even if an OD has known causal genes but if
there is no protein interactome data available then we
cannot use VS for such cases. An alternative approach
would be to consider other types of networks (coexpres-
sion or functional networks). Second, it is important to
note that the prioritization by our approach can only be
as accurate as the current protein interactome data are.
Third, if a seed gene has only one known interaction
then that interactant will be ranked higher.
Methods
Data resources
The ODs and causal gene information was downloaded
from Orphanet [10]. We merged some of the OD sub-
types of a single disease based on their given disorder
names as described previously [5,8]. From this, we
selected 172 ODs that have at least five causal genes.
The total number of genes across 172 selected diseases
was 1598. The human protein interactome used in this
study was compiled from several resources [49-54] with
both redundant interactions and self-loops removed.
Prioritization methods
We performed a leave-one-out cross-validation using the
172 ODs and 1312 OD causing genes that exist in PPI net-
work. We used the human protein interaction network as
the global network to evaluate the prioritizing performance
of VS and other two methods. The human protein interac-
tome used in our study contains protein-protein interac-
tions from large-scale yeast two-hybrid experiments
[49,50], computational predictions [51], and curation of the
literature [52-54], with both redundant interactions and
self-loops removed. The assembled PPI network consists of
11,765 proteins and 69,167 interactions. During each set of
a validation trial, one seed gene (“target gene”) from one of
the selected 172 ODs was picked out and mixed with 99
random genes from PPI network to form a test set of 100
candidate genes. The remaining seed genes of an OD were
used as the training set. The test set genes were then prior-
itized using the three approaches: PRP (with back probabil-
ities 0.3. and 0.05), ICN, and VS-based approach. During
each run, the rank of the “target gene” was noted. We eval-
uated the performance of each algorithm in terms of the
success rate versus rank cut-off (k). If the “target gene” is
ranked among the top k in a particular validation run, it is
considered as a ‘success’. The validation runs are repeated
until all the seed genes have been used as the target gene
and their ranks are obtained. The “success rate” is defined
as the ratio of successful validation runs and the total vali-
dation runs for all the existing OD genes from 172 ODs.
The same strategy was followed for all the three algo-
rithms. In case of PRP which is a parameter-based method,
we selected a back probability of 0.3 since we have shown
previously that the performance of PRP in ranking candi-
date disease genes was best at p = 0.3 [28].
Figure 5 Venn diagram comparing the top 20 ranked candidate genes for cone rod dystrophy using PRP (0.3), ICN, VS, and
ToppGene.
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Test set genes for identifying and ranking OD
candidate genes
For identifying and ranking novel OD candidate genes, we
used the immediate neighbors of known OD genes as the
test set. The immediate neighboring genes of selected
ODs’ causal genes were compiled based on (a) protein
interactions; (b) functional linkage network [32,33]; and
(c) literature co-citations. The protein interactome data as
described earlier was compiled from several resources
[49-54]. The functional linkage network-based candidate
gene sets were derived from two resources: (i) HumanNet,
a probabilistic functional gene network of Homo sapiens
[33] and (ii) functional protein interaction network built
upon expert-curated pathways [32]. The test set genes
based on literature co-citations were compiled using the
OMIM database. Briefly, for the selected ODs, we identi-
fied the corresponding OMIM records, which summarize
results from publications about gene-disease relationships.
For the OD mapped OMIM mapped records, we first
extracted the cited literature (links to PubMed records for
the references cited in an OMIM entry) in the OMIM
records. Using this OD-related PubMed records, we
extracted the related genes from the ‘gene2pubmed’ file
from NCBI [55]. For a given OD with known causal genes,
we pooled all neighboring genes (immediate neighbors or
direct interactants) of causal genes from different sources
and used it as a test set for ranking in the global protein
interactome using VS-based approach.
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